> Currently with Formel Labs Pvt limited as CSO and Site Head> Leading chemical R&D (CRD), analytical R&D (ARD), developmental QA (DQA) and Technology Transfer (TT)> Responsible for overall scientific and technology development and scale up/commercialisation> Oversees regulatory filling and approval> Stakeholder of Site BU and overall organisation P&L

> Assisted in turning the start-up profitable in 3rd year of commercial operation> Led Chemical R&D Division comprising of a team 45 scientists> Built strategic marketing strategy and revenue plan for the establishment of the vertical, and engaged with the buildout and construction of this formal organisation. > Assisted in control of variable and other costs to project real-world P&L statement from lab development till commercialisation.> Collaborated with manufacturing, quality, regulatory and supply chain; prioritisation of features and alignment to in-market strategy.> Worked with customers to gain stakeholder feedback about how services can solve problems each particular product> Led team for development and commercialisation of NCE and COVID-19 advanced intermediates > Led regulatory team filling of several drug master files during initial phase of operation> Ensured norms of Quality by Design (QbD) during process development> Established process robustness by evaluating critical process parameter (CPP), Design of Experiment (DoE) and Quality Risk Management (QRM)

> Led API-R&D Division with a team of 35 scientists to develop in-house as well as CRAMs API projects by co-ordinating with all the relavant stake-holders> Directed process optimization for in-house API products such as Ivabradine, Olmesartan and Ibrutinib.> Actively led Ind-swift team while interactive with customers for CRAMs projects> Provided assistance to multiple clients across the globe such as Kongo Pharmaceuticals, Nissan Chemicals and Pharmathen> Involved in the process optimization and contract manufacturing of API intermediates viz., Ezetimibe, and APIs such as Ropinirole, Valganciclovir and Metaraminol for privileged clients.> Managed the entire product development including requirement analysis, finalising specifications, validating designs, prototype development and component testing activities> Managed Setting up, calibrating, operating and maintaining a variety of laboratory and/or field research equipment as specified by the requirements of the research study> Monitored carryover of critical and Genotoxic Impurities (GTIs) and control thereof by ensuring purging factor evaluation

> Directed API process development projects of oncology and anti-diabetic type 2 therapeutic categories with 25 scientists> Merit of holding 14 patent applications filed on the process development of APIs and intermediates thereof> Formulated prep HPLC techniques for plant validation of high potent APIs > Provided assistance to multiple customers for P-IV filling of APIs viz., Cabazitaxel and CarfilzomibSubmitted all required documents to Regulatory Team during various stages of development for filling of drug master file and supporting filling of several DMFs > Achieved indigenous development and/or commercialization of 10 products such as Carfilzomib, Pazopanib, Dapagliflozin, Empagliflozin, Cabazitaxel, Sunitinib, Docetaxel, Cisplatin, Carboplatin and Oxaliplatin, > Took part in many National & International technology events and product strategy workshops to understand future technology & product needs

> Led three projects at a given times with a team of 12 scientists > Inventor of 4 patents> Developed non-infringing, cost –effective, patented process for the APIs and API intermediates viz., Posaconazole, Voriconazole, Nateglinide and Rufinamide.> Project Manager: Interaction with interdisciplinary teams such as AR&D, DQA, IPM, SCM and Tech Transfer on regular basis for troubleshooting and planning/ managing of the projects

> Developed Indo-US Green Chemistry Network Center (GCNC) Award winning technology associated to conversion of a pollutant of Ranitidine process to a solvent (DMSO).> Co-author of an international publications and 6 patents> Developed process for APIs and intermediate viz., Eletripton, Sumatripton, Valsartan, Solifenacine, Bicalutamide, Ranitidine, Nizatidine, Paclitaxel side chain, docetaxel side chain and Diltiazem.> Successfully Guided multidisciplinary teams of 10 Scientists (Process development, CRO and IPM)

• Led projects with 6 scientists• Developed non-infringing cost –effective process for the APIs and API intermediates.